Clinical Trial Update: Yttrium Y 90 Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

View source ↗

Summary

A City of Hope Medical Center trial evaluating Yttrium-90 radiolabeled glass beads for unresectable liver cancer is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Yttrium-90 radiolabeled glass beads (yttrium-90 radiolabeled glass beads)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Liver Cancer | Status: NO_LONGER_AVAILABLE